Treatment
Medication clinical trials
We’re tracking 7,138 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07701512RecruitingPhase 2
Febuxostat for brain bleed patients managed without surgery
This trial tests if febuxostat, a medicine used for gout, can help people recover from a brain bleed (intracranial hemorrhage) when surgery is not needed. It may reduce inflammation and improve outcomes.
Al Mansurah, Dakahlia GovernorateAges 18 years+ - NCT07704138Recruiting
Testing process-based therapy for depression and anxiety
This trial tests a type of talking therapy called process-based therapy to see how well it works in everyday care. It focuses on treating depression or anxiety and helps therapists learn how to make better treatment decisions.
Frankfurt am Main, HesseAges 18–65 - NCT07705906Recruiting
Robot-assisted leg training for mobility recovery
This trial tests a robot device to help people with leg weakness from stroke, spinal cord injury, or joint surgery improve their walking. It may be a good option if you are medically stable and can work with the robot safely.
Dhaka, Dhaka DivisionAges 18–70 - NCT05629494RecruitingPhase 4
Ibuprofen vs PSA blood test for prostate evaluation
This trial studies whether an anti-inflammatory medicine (ibuprofen) changes prostate-specific antigen (PSA) blood test results to help decide on next diagnostic steps like MRI or biopsy. It may help people with an elevated PSA understand whether follow-up testing is more or less likely to be needed.
Chicago, IllinoisAges 18–80 - NCT06200311Recruiting
Atrial fibrillation ablation to prevent heart damage in women and men
This trial tests whether a procedure called AF ablation (which treats irregular heartbeats) can stop further damage to the heart muscle caused by atrial fibrillation. It may help people with both atrial fibrillation and early signs of heart muscle weakening.
GroningenAges 65–80 - NCT06649565Recruiting
AI model to predict breast cancer treatment response
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06533410Recruiting
Testing a new Chinese pain scale for fibromyalgia diagnosis
This study tests a new Chinese questionnaire to help doctors diagnose fibromyalgia more accurately. It is for people with long-lasting, widespread pain who can fill out a simple form.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05784311RecruitingPhase 4
Longer vs shorter antibiotic prevention after pancreatoduodenectomy
This trial compares a standard length of preventive antibiotics versus a longer course after Whipple surgery to see if it lowers infection risk without causing extra side effects. It targets people considered higher risk for contamination of bile during surgery.
Leiden, South HollandAges 18–90 - NCT06652087Recruiting
Testing rifaximin for heart failure with preserved pumping
This trial tests whether the antibiotic rifaximin (taken by mouth) can improve heart function in people with a type of heart failure where the heart pumps well but is still weak (HFpEF). Rifaximin might help by changing the bacteria in your gut.
MoscowAges 18–80 - NCT06650969Recruiting
Early detection of cognitive decline in type 2 diabetes
This study is looking at ways to catch early thinking and memory changes in people with type 2 diabetes. By joining, you may help doctors learn how to spot problems sooner and find better ways to help.
Nanjing, JiangsuAges 45 years+ - NCT04593589RecruitingPhase 1
Stem cell transplant to protect salivary function after oral cancer
This Phase 1 study tests whether transplanting stem cells into the submandibular gland can help restore saliva function after surgery and radiation for oral cavity squamous cell cancer. You may be considered because you recently had tumor removal and radiation aimed at the neck area, which can damage salivary glands.
GroningenAges 18 years+ - NCT07690761Enrolling by invitationPhase 2
Rituximab and Zanubrutinib for hairy cell leukemia
This trial tests a combination of two targeted drugs, rituximab and zanubrutinib, for people with hairy cell leukemia or its variant. It aims to see if this therapy works for those who have already had one type of chemotherapy or who cannot take a standard treatment called purine analogs.
HaifaAges 18 years+ - NCT07691775RecruitingPhase 1/Phase 2
F18 FBPA PET/CT scan for solid tumors
This trial tests how well a special PET/CT scan with a radioactive tracer called F18 FBPA can detect different types of solid tumors. It aims to see if this scan is safe and effective at finding tumors.
TaipeiAges 18–80 - NCT06653452Recruiting
PET/MRI for rectal cancer treatment response
This study uses a special scan called PET/MRI to see how well treatment works for locally advanced rectal cancer before surgery. It may help doctors choose the best treatment plan for you.
Beijing, Beijing MunicipalityAges 18–75 - NCT06653478Recruiting
Smarter cancer risk assessment using all your medical info
This study is testing a new way to use medical images, records, and other information to better assess cancer risk and guide treatment. It may be a good fit if you have a suspicious spot in your lungs, stomach, or colon, or if you are healthy and want to help with early cancer detection research.
Wuhan, HubeiAges 18–75 - NCT07693023Enrolling by invitation
Advanced practice nurses for better team care
This trial studies how advanced practice nurses (APNs) can improve care for specific patient groups. It looks at how the whole hospital team works together with these specially trained nurses.
Vöcklabruck, Upper AustriaAges 18–70 - NCT07696130Recruiting
Trifocal lens implant study for cataract or presbyopia
This study tests a new type of trifocal lens implant to see how well it improves vision at all distances after cataract or lens replacement surgery. It may help you become less dependent on glasses.
Szczecin, ZachodnipomorskieAges 50–75 - NCT07689656RecruitingPhase 1/Phase 2
PET imaging study for prostate cancer using a new tracer
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
Wuhan, HubeiAges 18–80 - NCT07691827Recruiting
Study of sperm problems linked to inherited genetic mutation
This study is investigating a specific genetic mutation in the MT-ND1 gene that can be passed from mother to son and may cause sperm production problems. It compares men with severe sperm issues to those with normal sperm production to understand the genetic cause.
Guangzhou, GuangdongAges Any age - NCT07696715Recruiting
Timing of immunotherapy for melanoma
This trial studies the timing of a standard immunotherapy combination for advanced melanoma that cannot be removed by surgery or has spread. It aims to understand how timing affects treatment results.
AmsterdamAges 18 years+ - NCT07694778Recruiting
Functional dyspepsia in rural Bangladesh
This study looks at how common functional dyspepsia (stomach discomfort without a clear cause) is among adults living in a rural area of Bangladesh. It aims to understand who is affected and what factors might be involved.
DhakaAges 18 years+ - NCT07696000Recruiting
Nutrition therapy for inflammation in schizophrenia
This trial tests whether a structured medical nutrition plan can reduce inflammation in people with schizophrenia who are on stable antipsychotic medication. If you are hospitalized and able to eat normally, this study may help you understand how diet affects your health.
MedanAges 18–60 - NCT07691801Recruiting
Testing a New Method to Diagnose a Common Cause of High Blood Pressure
This study uses a new, precise blood test to help diagnose primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. It compares results from healthy volunteers and patients with suspected primary aldosteronism to see if it works better than current methods.
Beijing, Beijing MunicipalityAges 18–70 - NCT07689643RecruitingEarly Phase 1
Radioactive drug plus immunotherapy for FAP-positive lung cancer
This trial tests a new treatment that uses a radioactive medicine called [177Lu]Lu-RTX-2358 combined with immunotherapy (a type of drug that helps your immune system fight cancer). It is for people with advanced non-small cell lung cancer whose tumors have a specific marker called FAP.
Wuhan, HubeiAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,138 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.